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Abstract: Hypoxic-ischemic encephalopathy (HIE) is still a major cause of neonatal death and
disability as therapeutic hypothermia (TH) alone cannot afford sufficient neuroprotection. The present
study investigated whether ventilation with molecular hydrogen (2.1% H2) or graded restoration of
normocapnia with CO2 for 4 h after asphyxia would augment the neuroprotective effect of TH in a
subacute (48 h) HIE piglet model. Piglets were randomized to untreated naïve, control-normothermia,
asphyxia-normothermia (20-min 4%O2–20%CO2 ventilation; Tcore = 38.5 ◦C), asphyxia-hypothermia
(A-HT, Tcore = 33.5 ◦C, 2–36 h post-asphyxia), A-HT + H2, or A-HT + CO2 treatment groups.
Asphyxia elicited severe hypoxia (pO2 = 19 ± 5 mmHg) and mixed acidosis (pH = 6.79 ± 0.10).
HIE development was confirmed by altered cerebral electrical activity and neuropathology. TH was
significantly neuroprotective in the caudate nucleus but demonstrated virtually no such effect in
the hippocampus. The mRNA levels of apoptosis-inducing factor and caspase-3 showed a ~10-fold
increase in the A-HT group compared to naïve animals in the hippocampus but not in the caudate
nucleus coinciding with the region-specific neuroprotective effect of TH. H2 or CO2 did not augment
TH-induced neuroprotection in any brain areas; rather, CO2 even abolished the neuroprotective effect
of TH in the caudate nucleus. In conclusion, the present findings do not support the use of these
medical gases to supplement TH in HIE management.
Keywords: hypoxic-ischemic encephalopathy; perinatal asphyxia; therapeutic hypothermia; piglet
model; hydrogen ventilation; brain-derived neurotrophic factor
1. Introduction
Hypoxic-ischemic encephalopathy (HIE) is defined as acute/subacute brain injury elicited by
asphyxia in the perinatal period [1,2]. The hallmarks of perinatal asphyxia include severe systemic
hypoxia, hypercapnia, acidosis, and/or reduced cerebral blood flow. HIE is diagnosed based on the
clinical presentation of encephalopathy and laboratory findings of recent asphyxia often showing
multi-organ involvement in hypoxic-ischemic injury [3,4]. HIE is a major cause of neonatal death and
long-term disability worldwide and the medical costs of HIE management can be expressed in billions
of dollars in developed countries alone [5,6]. Therefore, neuroprotective therapies reducing brain
injury and also preventing multi-organ failure are urgently needed, even though mild whole-body
hypothermia treatment (therapeutic hypothermia; TH) has been successfully implemented into the
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clinical practice and was shown to improve long-term outcome measures [1]. However, TH alone is
clearly insufficient for the successful treatment of all HIE patients; on average, seven infants affected
with severe HIE must be treated with TH to reduce by one the number of deaths or major disabilities [7].
Therefore, further preclinical research is warranted to identify additional treatment options that
can complement the neuroprotection afforded by TH. The term newborn pig provides a suitable
large-animal experimental model for translational HIE research as its gyrencephalic brain structure,
brain developmental stage at birth, cerebral metabolic rates of glucose and oxygen are all comparable
to term human babies [8–10]. Notably, TH was also shown to be effective in a piglet HIE model, lending
support to the model’s translational value [11,12]. Among the many putative neuroprotective therapies,
our research group focuses on inhaled neuroprotective gases as they offer a simple, straightforward
administration route that is feasible even under clinical conditions, as acute management of severely
asphyxiated babies often must include intratracheal intubation and mechanical ventilation. In the
present study, we assessed two previously reported neuroprotective gases: H2 and CO2.
Ohsawa et al. reported in their seminal paper that inhaled H2 was neuroprotective in an adult rat
stroke model [13], and it was also found to be effective in a rat HIE model as well [14]. Our research group
was the first to show H2-induced neuro-vascular protection in a piglet acute HIE model [15], and then
we characterized the beneficial effects of H2. We showed preserved neuro-vascular reactivity [16],
reduced neuronal injury in most brain regions studied, improved recovery of EEG [17], reduced
oxidative deoxyribonucleic acid (DNA) damage, limited microglial activation, and abolishment of
asphyxia-induced increases in neuronal cyclooxygenase-2 (COX-2) immunopositive neurons [18].
However, an additive neuroprotective effect of H2 and TH has not yet been demonstrated. Indeed,
a recent study investigated this in a piglet model [19]; however, there were no differences between
the TH and the TH + H2 treated animals in the neurological/neuropathological scores. A potential
cause for this finding was that all animals undergoing TH or TH + H2 fully recovered by the end of the
observation period, excluding the possibility to detect such differences in treatment efficacy [19].
Hypercapnia is a cardinal feature of asphyxia; however, postasphyxial CO2 levels also play
an important role in determining HIE outcome: hypocapnia was found to be an independent risk
factor for severe neurodevelopmental disability and death [20]. Furthermore, inhalation of CO2
immediately after experimental asphyxia, leading to a so-called graded restoration of normocapnia,
was shown to exert beneficial effects like reduction of seizure burden [21] and preservation of cerebral
oxygenation [22].
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophic factor family that
is highly expressed in the developing brain and plays an important role in regulating neural
proliferation, differentiation, and survival [23,24]. Upregulation of BDNF has been implied to
exert a neuroprotective effect in the hippocampus of newborn piglets following hypoxic stress [25].
Furthermore, BDNF upregulation was shown to be involved in TH-induced neuroprotection following
cardiac arrest in the adult rat brain [26], and it was also observed in newborn piglets exposed to TH after
hypoxic/ischemic stress [27]. BDNF has anti-apoptotic effects by blocking both caspase-independent
and dependent pathways acting on caspase-3 and apoptosis-inducing factor (AIF), respectively.
Although these genes were assessed in hypoxic or hypoxic-ischemic piglet models [25,27], the effect of
asphyxia on the gene expression patterns has not yet been explored.
Therefore, the major objective of the present study was to assess whether there was an additive
neuroprotective effect of H2 or CO2 when combined with TH compared to TH alone. To enhance
the translational value of our study, we modified our previously published piglet HIE model [17]
by eliciting asphyxia with lower FiO2 (4% instead of 6% O2) to represent more severe HIE patients
that would especially benefit from combined therapies and provided the current state-of-the-art
HIE management including TH. We also wished to start exploring the molecular mechanisms of
neuronal injury at the gene expression level; therefore, we studied expression changes in BDNF,
caspase-3, and AIF. We demonstrate that H2 or CO2 could not enhance the neuroprotective effect of
TH in any brain areas assessed with either neuropathology or electrophysiology. We also made novel
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observations on how TH modifies gene expression after asphyxia in our model that may contribute to
the neuroprotection.
2. Results
To address the major study objectives, five groups of anesthetized, instrumented animals were
used, and control brain samples were obtained from naïve (untreated control) animals as well
(Figure 1). Mortality of the applied asphyxia/HIE protocol was 12% (4/33): three piglets expired during
asphyxia before they could have been assigned to any treatment group, and only one piglet in the
asphyxia-hypothermia group was lost at 32 h of survival. Data from these animals were not included
in the study.
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Figure 1. Overview of the experim ntal protoc Untr ated nimals served as naïve controls for
neuropathology and gene expression studies; piglets in the control-normothermia group (C-NT)
were anesthetized, ventilated, and monitored but not subjected to asphyxia. Animals of the
asphyxia-normothermia group (A-NT) wer exposed to 20 min asphyxia induce by ventilation
with 4% O2–20% CO2 gas mixture. Animals in the asphyxia-hypothermia group (A-HT) were
cooled down to 33.5 ◦C, starting 2 h after reventilation, and were gradually rewarmed from 36 h
to normothermia by 0.5 ◦C/h in 10 h. H2-treatment was initiated at the onset of reventilation after
asphyxia (21%O2–2.1% H2, 4 h) and was combined with hypothermia (A-HT + H2 group). In a similar
fashion, CO2-treatment was initiated at the onset of reventilation after asphyxia and was combined
with hypothermia (A-HT + CO2 group). In ord r to achieve graded restoration of normocapnia,
the animals were ventilated first with 21% O2–10% CO2 for 2 h and then with 21% O2–5% CO2 for 2 h
before switching back to air. Arterial blood samples were collected and visual evoked potential (VEP)
measurements were performed at the marked time points.
2.1. Physiological Parameters during Asphyxia and HIE Development
At the beginning of the experiments, piglets in all groups had similar physiological values [28] of
core temperature (38.5 ± 0.2 ◦C), mean arterial blood pressure (MABP; 57 ± 10 mmHg), and heart rate
(HR; 140 ± 20 bpm), r spectively (Fi ure 2A–C). Immediately after the ons t of asphyxia, MABP and
HR were first markedly raised (at peak, they were 73 ± 12 mmHg and 206 ± 22 bp , respectively)
but then continuously decreased by the end of the asphyxia (at the nadir, they were 38 ± 17 mmHg
and 138 ± 33 bpm, respectively). Reventilation resulted in quick restoration of MABP and HR; then,
MABP values were kept in the physiological range and the values did not differ significantly among
the experimental groups throughout the 48 h observation period (Figure 2B). After the onset of the TH
treatment, core temperatures differed between the normothermic and hypothermic animals (Figure 2A);
also, a clear reduction in HR developed in the hypothermic groups of animals compared to the
normothermic ones (Figure 2C).
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however, there were no significant differences in MABP. Data are shown as mean ± SEM. p < 0.05
* normothermia vs. hypother ia groups.
The monitored blood chemistry parameters such as arterial blood pH, blood gases, glucose,
and lactate levels were similar and within the normal range in all groups at baseline (Figure 3A–F).
However, blood analysis at the end of asphyxia revealed severe combined metabolic and respiratory
acidosis with corresponding hypercapnia and lactacidemia (Figure 3A,B,E), as well as hypoxemia
(Figure 3C) and negative base excess (Figure 3F), that were similar in all groups exposed to asphyxia.
After asphyxia, blood gases quickly returned to baseline levels and then they were not statistically
different from the corresponding values of the control-normothermia group, with the notable exception
of the asphyxia-hypothermia+CO2 group. In this group, the continued ventilation with 10% or 5%
CO2 was reflected in the gradual restoration of pH and pCO2 at 1 and 4 h, respectively (Figure 3A,B).
The elevated blood lactate levels also gradually returned to baseline levels; they were still significantly
elevated at 1 h after asphyxia in all groups compared to the control-normothermia group, but there
was no difference among the groups at any time point afterwards (Figure 3E). The blood glucose
levels remained slightly elevated at 1 h of reventilation but then returned to baseline values by 4 h of
reventilation (Figure 3D).
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elevated along with large drops in base excess (F), indicating the metabolic response to asphyxia.
After asphyxia, arterial pH and pCO2 values reflected the effect of 10–5% CO2 ventilation in the
graded reduction of normocapnia group (A-HT + CO2); otherwise, reventilation restored most of the
parameters by 4 h, and they were not significantly different from baseline levels afterwards. Experimental
groups: control-normothermia (C-NT), asphyxia-normothermia (A-NT), asphyxia-hypothermia (A-HT),
A-HT supplemented with H2 (A-HT + H2) or CO2 (A-HT + CO2), respectively. Bars and whiskers
represent mean ± SEM, p < 0.05 * vs. all groups; ‡ vs. C-NT; † vs. A-NT; # vs. A-HT.
Brain Interstitial H2 Concentration Measurements
To show the efficacy and the dynamics of the applied H2-inhalation protocol to increase brain
H2 levels, cerebrocortical H2 levels were determined in three additional normothermic, normoxic
control animals, and they were found to increase quickly and reach steady-state levels in 10–15 min;
the average H2 concentration was 13.1 ± 3.4 µM (Figure 4).
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Figure 4. Cerebrocortical H2 concentration changes during 2.1% H2 ventilation. H2 gas was ventilated
to the animals (n = 8 trials from n = 3 piglets) until steady state H2 levels were reached at 10–15 min
after initiation of H2 ventilation (grey lines—individual traces, bold black line—mean).
2.2. Electroencephalography (EEG) Analysis
At baseline conditions before asphyxia, similar continuous EEG activity (>25 µV amplitude) could
be observed in all groups. The control-normothermia group maintained continuous, high-amplitude
EEG activity throughout the observation period (Figure 5A). The EEG became isoelectric within
1–2 min after the onset of asphyxia; then, the EEG activity regenerated progressively but showed large
inter-individual variability (Figure 5B,E). The total scores showed well the effect of asphyxia, but there
were no significant differences among the treatment groups (Figure 5F).
The restoration of EEG activity in the different groups was also quantitatively analyzed after
rewarming toward the end of the 48 h observation period by determining power spectral density
(PSD; Figure 6A, Table S2), spectral entropy (SpEnt; Figure 6B), and visual evoked potentials (VEP;
Figure 6D). The effect of asphyxia on PSD in all frequency ranges is conspicuous (Figure 6A). Although
the asphyxia-normothermia group shows higher PSDs, especially at lower (δ-θ) frequencies, than the
hypothermia-treated groups, this was found to be due to the higher incidence of generalized seizures,
abnormal waveforms, and spikes; for example, see Figure 6C—these seizures were virtually absent
in the hypothermia-treated groups. SpEnt revealed high temporal complexity in all frequency
bands that were due to the anesthesia alone in the control-normothermia group, while they were
affected by asphyxia-induced changes in the other four groups. Comparing these, SpEnt values
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were increased in the hypothermia-treated groups compared to the asphyxia-normothermia group,
especially at the higher frequency (α-β) ranges (Figure 6B). Furthermore, the lower temporal
complexity shown by SpEnt in the asphyxia-normothermia group is also confirmed by the
calculated lowest instantaneous spectral entropy (InstSpEnt) representing the whole EEG signal
determined for this group. InstSpEnt values were 0.684 ± 0.054, 0.734 ± 0.073 *, 0.699 ± 0.69,
and 0.723 ± 0.075 * for asphyxia-normothermia, asphyxia-hypothermia, asphyxia-hypothermia+H2,
and asphyxia-hypothermia+CO2 groups, respectively (* p < 0.05, significantly different from the
asphyxia-normothermia group). VEP waveforms were severely affected by asphyxia; the changes were
dominated by attenuation of the P100 component amplitude. Compared to the respective baseline
(pre-asphyxia) values, attenuation of the P100 component was significant in all groups exposed to
asphyxia except for the asphyxia-hypothermia group (Figure 6D).Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 6 of 22 
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Figure 5. The EEG recordings were scored using a previously published [14] amplitude-based
scoring system (Table S1), where higher scores represent progressive deterioration of electrical
activity. Experimental groups: control-normothermia (C-NT), asphyxia-normothermia (A-NT),
asphyxia-hypothermia (A-HT), A-HT supplemented with H2 (A-HT + H2) or CO2 (A-HT + CO2),
respectively. (A–E): The black line shows the median values whereas the shaded area represents
the 25th-75th interquartile range. C-NT animals were characterized by continuous EEG activity and
low EEG scores during the entire experiment, whereas asphyxia induced isoelectric EEG that was
followed by slow regeneration of electrical activity in all experimental groups in the observation period.
There were no significant differences among the treatment groups at any time points; however, the
large intra-individual variability can be appreciated. (F): The sum of EEG scores during the observation
period in the experimental groups. The black line represents the median, the box the interquartile
range, the whiskers the 10th-90th percentiles, the bullets the raw values. The summated EEG scores
were significantly higher in the A-NT, A-HT + H2, and A-HT + CO2 asphyxia groups compared to
the C-NT (* p < 0.05) group, but this was not the cause in the A-HT group, suggesting that the best
outcome was found in these animals.
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Figure 6. (A) Average tr l density (PSD) changes in each experimental group for the four
main frequency ba s t t e e f t e 48 h observation period. All PSDs were normalized to their
respective control values for each lead. Delta, theta, alpha, and beta PSDs across the different leads
show significant differences bet een each group. (B) Corresponding individual spectral entropy
(SpEnt) values in each group. (C) Representative spectrogram of a generalized seizure in a piglet
from the asphyxia-normothermia group (~7 Hz) which could be detected by all 9 leads. Below the
spectrogram, we highlighted a 2 s-long spike-and-wave seizure waveform. (D) Representative heat
map of the recorded VEP trials with their average VEP waveform below. The two box plots show the
latency and peak amplitudes of the P100 components at the 48 h time point in each group, normalized
to the respective pre-asphyxia baseline values. The black line represents the median, the box the
interquartile range, the whiskers the 10th–90th percentiles, the bullets the raw values. Experimental
groups: control-normothermia (C-NT), asphyxia-normothermia (A-NT), asphyxia-hypothermia (A-HT),
A-HT supplemented with H2 (A-HT + H2) or CO2 (A-HT + CO2), respectively. Data are mean ± SD;
* vs. C-NT, † vs. A-NT, ‡ vs. A-HT, p < 0.05.
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2.3. Neuropathology
Neuropathology assessment confirmed severe HIE development induced by asphyxia, shown by
increased neuronal damage compared to naïve or control-normothermia animals, in virtually all studied
brain regions. TH appeared to mitigate the neuronal damage in the neocortex, the caudate nucleus,
the putamen, and the thalamus; however, statistically significant neuroprotection was detected only in
the caudate nucleus. In contrast, TH could not affect the severe neuronal damage in the hippocampus.
Most importantly, the additional treatments with H2 and CO2 did not provide any additional beneficial
effects; in contrast, in several regions, such as the neocortex or the basal ganglia, they appeared
to abolish the neuroprotective effect of TH. In fact, neuronal damage in the caudate nucleus was
significantly higher in the asphyxia-hypothermia+CO2 group compared to the asphyxia-hypothermia
group (Figure 7).
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Figure 7. Neuronal injury evaluated at 48 h after asphyxia in the different cortical and subcortical
regions. (A): In the neocortex, neuropathology scores suggested that asphyxia-induced neuronal injury
was mitigated by hypothermia; however, there were no statistically significant differences among
the groups (lines, boxes, whiskers, and bullets represent the median, the interquartile range, the
10th-90th percentiles, and raw data, respectively). (B–F): In the other assessed regions, cell counting
revealed no significant differences in the low percentage of damaged neurons between the naïve
and control-normothermia (C-NT) groups. Compared to the C-NT group, severe neuronal damage
was detected in virtually all areas in the groups that were subjected to asphyxia. Neuronal damage
was similar in both the CA1 and the CA3 hippocampal subfields in all groups exposed to asphyxia,
despite hypothermia treatment. However, in the asphyxia-hypothermia (A-HT) group, a significant
decrease in percentage of damaged neurons in the caudate nucleus was observed compared to the
asphyxia-normothermia (A-NT) group, and there was a similar tendency in the putamen and the
thalamus. Importantly, co-treatment with H2 or CO2 to achieve graded restoration of normocapnia
did not augment the hypothermia-induced neuroprotection (A-HT + H2 and A-HT + CO2 groups,
respectively). Instead, a significant increase in neuronal damage was observed in the caudate nucleus in
the A-HT + CO2-treated group compared to the A-HT group. Data are mean ± SEM; bullets represent
raw data, * vs. A-NT; † vs. A-HT, p < 0.05; statistical significance from naïve or C-NT groups is not
shown. Representative photomicrographs are shown in Supplementary Figures S1–S5.
2.4. Gene Expression Studies
Based on the neuropathology data, we selected four brain regions—the frontal cortex, the occipital
cortex, the hippocampus, and the caudate nucleus—that differed from each other both in the degree
of neuronal injury after asphyxia and the efficacy of TH to exert neuroprotection. We determined
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changes in BDNF, AIF, and caspase-3 expression to assess the impact of asphyxia and TH (Figure 8).
There were no significant differences in the mRNA levels of any genes in any region between
the control-normothermia and asphyxia-normothermia groups. Furthermore, as compared with
the asphyxia-normothermia group, mRNA levels for all three genes remained unchanged in the
frontal cortex in the asphyxia-hypothermia animals (Figure 8A). However, in the other three regions,
BDNF and AIF mRNA levels were significantly increased in the asphyxia-hypothermia group compared
to the asphyxia-normothermia animals (Figure 8B–D). Caspase-3 mRNA levels were also induced by
hypothermia after asphyxia in the occipital cortex and the hippocampus (Figure 8B,C) but not in the
caudate nucleus (Figure 8D).
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Figure 8. Gene expression data for BDNF, AIF, and caspase-3 genes in four different brain regions.
(A): In the frontal cortex, BDNF mRNA levels were significantly higher in the naïve (untreated) group,
but they were very similar in the control-normothermia (C-NT), asphyxia-normothermia (A-NT),
and asphyxia-hypothermia (A-HT) groups. AIF and caspase-3 levels were also very similar in all four
groups. (B): In the occipital cortex, the mRNA levels of all three genes were significantly elevated in
the A-HT group compared to the A-NT group. (C): In the hippocampus, an identical pattern of gene
expression was observed. (D): In the caudate nucleus, BDNF and AIF but not caspase-3 mRNA levels
were significantly increased in the A-HT group compared to the A-NT group. Lines, boxes, whiskers,
and bullets represent the median, the interquartile range, the 10th–90th percentiles, and raw data,
respectively. * vs. A-NT p < 0.05.
3. Discussion
The major findings of the present study are the following: (1) we employed a severe HIE model in
which TH alone was unable to prevent severe neuronal injury; (2) we determined InstSpEnt and SpEnt
in addition to PSD and VEP to characterize electrophysiological changes during HIE-development
in our piglet model; (3) we made novel observations on region-specific gene expression changes
induced by asphyxia or TH, starting to decipher the underlying mechanisms of the region-dependent
neuroprotective effect of TH, and (4) we found that neither molecular H2 nor graded restoration of
normocapnia with CO2 could provide an additive neuroprotective effect to TH in this piglet HIE model.
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In the present study, we employed a severe HIE piglet model to represent the group of HIE patients
in which TH alone is unlikely to prevent the development of adverse neurological consequences.
These affected infants would benefit the most from adjunct neuroprotective therapies complementing
the neuroprotective effect of TH. Two such promising adjunct medical gas therapies, namely H2
ventilation and graded restoration of normocapnia achieved with CO2 ventilation, have been tested
in the present study. Hypothermia was initiated 2 h after asphyxia, in agreement with previous
studies using hypothermia-induced neuroprotection in different HIE piglet models [29,30]. The 48 h
observation period allowed most of the asphyxia-induced neuronal damage to develop [30]; it also
enabled us to perform the recommended slow rewarming protocol (∆T/t = 0.5 ◦C/h, 10 h) to prevent
adverse systemic effects of cooling. However, neuronal damage may continue beyond the observed
period, and the 34 h duration of therapeutic level TH employed in the present study may have been
still suboptimal to exert the maximal neuroprotective effect of TH. This is a clear limitation of our
study; indeed, neuroprotection afforded by 72 h local brain cooling was clearly superior to 48 h cooling
in prenatal sheep [31]. Furthermore, the 2 h delay in hypothermia treatment initiation used in the
present study may have also limited the neuroprotective effect of TH, although this would have likely
facilitated the detection of potential additive effects as these were initiated immediately after asphyxia
in the present study. These limitations should be considered when designing future studies to assess
new treatments combined with TH.
EEG recording was used to determine a host of parameters aimed to characterize the functional
consequences of asphyxia and to assess the efficacy of neuroprotective treatments in the present study.
PSDs are easy to compute and clearly reflect the current functional state of the cortex as well as showing
altered neuronal activity including seizures [32]. Studying entropy is more complicated due to the
chaoticity and non-linearity of the biological (e.g., EEG) signal. InstSpEnt and SpEnt are relatively
simple parameters that yield information on the instantaneous state of the whole signal and the normal
power distribution in the respective frequency domain, respectively. Determination of InstSpEnt and
SpEnt are commonly used approaches in electrophysiology [33,34] but not employed frequently in
neonatology. In our study, we could show that, in the asphyxia-normothermia group, the higher PSD
values were accompanied by lower InstSpEnt and SpEnt values, showing that low-entropy abnormal
rhythmic (seizure) activities contributed more to the EEG signal than in the asphyxia-hypothermia
groups. The higher InstSpEnt and SpEnt values measuring EEG signal complexity found in the
hypothermia-treated groups are in concert with the neuroprotective effect of TH, even though
hypothermia in this study was unable to restore PSDs after asphyxia. These findings help to establish
novel outcome measures for translational HIE research or even the development of an artificial
intelligence based toolbox for neonatal EEG monitoring. VEPs are also good predictors of neurological
functional alterations in newborns [35,36]. Asphyxia resulted in abnormal VEP waveforms altering
both signal latency and amplitude in all groups, similar to observations in animal models [37] or human
neonates [38]. We observed significant amplitude decreases in all experimental groups; the smallest
reduction was observed in the asphyxia-hypothermia group. All electrophysiology parameters (PSDs,
InstSpEnt, SpEnt, VEP) indicated that the combination of hypothermia with either molecular H2 or
graded restoration of normocapnia was not superior to hypothermia alone.
Neuropathology essentially confirmed our electrophysiology findings in the present study:
asphyxia induced pronounced neuronal injury, especially in the hippocampus, the caudate nucleus,
and the putamen, while neuronal damage was more modest in the neocortex. TH significantly
reduced injury only in the caudate nucleus, in which region neuronal injury was most pronounced.
Thus, in theory, our HIE model was sufficient to show whether the applied adjunct neuroprotective
therapies could in fact facilitate hypothermia-induced neuroprotection to reach statistical significance.
However, neither molecular H2 nor graded restoration of normocapnia with CO2 was able to facilitate
neuroprotection; instead, in the caudate nucleus, the combination of TH with graded restoration of
normocapnia significantly abolished hypothermia-induced neuroprotection. Similar tendencies were
present in virtually every assessed region for both treatments. Our study has a clear limitation which
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we must declare: the observed statistical power of the multiple comparisons (ranging between 0.11
and 0.84) were low in some regions to be sure to avoid type II errors. However, we believe that
this limitation may have only prevented us from not showing the adverse interaction of the adjunct
treatments with TH, but a marked additive neuroprotective effect of these was not overlooked in
any regions.
Molecular H2 has become an intensively studied cytoprotective/neuroprotective medical gas in
the last decade; for recent reviews of the widespread beneficial effects of H2, please refer to [39–42].
Concerning HIE, many rodent studies using the Rice–Vannucci model of hypoxic-ischemic stress
established the neuroprotective effect of H2 [14,43–46]. Our research group was the first to show the
beneficial effect of H2 in a piglet HIE model, as H2 was found to preserve neurovascular function both
in the acute (at 1–2 h) and in the subacute (at 24 h) after asphyxia [15,16]. Furthermore, using more
severe asphyxia that was very similar to the one employed in the present study, H2 was shown to
significantly reduce neuronal injury, oxidative stress, and neuroinflammation assessed also at 24 h after
asphyxia [17,18]. In the present study, even more severe stress was employed (i.e., ventilation with 4%
instead of 6% O2 during asphyxia). This level of hypoxia during asphyxia was chosen as we found
that, if using 6% O2, hypothermia alone was so neuroprotective, this would have likely prevented
the assessment of combined hypothermia+H2 treatment (unpublished observations). This potential
limitation appears to have manifested in a recent study, in which both the hypothermia and the
hypothermia+H2 treated piglets after asphyxia made a very similar, essentially full recovery, excluding
the possibility for statistically valid comparisons between the efficacy of the treatments [19]. In the
present study, we used an identical H2 administration as in our previous studies; namely, H2 treatment
was applied in the first four hours of reventilation/reoxygenation. We now also showed for the first
time using H2-selective microelectrodes that, in this experimental model, the applied H2 administration
protocol results quickly (in 10 min) in steady-state interstitial brain H2 levels of ~10–20 µM, and these
values are in accordance with blood H2 levels found in rats in which H2-induced neuroprotection
against ischemic stress was demonstrated [13]. As we did not test cerebral H2 levels after asphyxia
or during TH, the changes in cerebral blood flow in either condition could affect the kinetics of H2
level changes; this is also a clear limitation of the findings. However, the applied H2 administration
route was shown to be appropriate for quick delivery of the putative neuroprotective gas in the
immediate/early reoxygenation period after asphyxia.
In contrast to H2, the neuroprotective actions of CO2 in HIE are less established. It is clear
that, during hypoxic stress (8% O2 inhalation), low CO2 levels (hypocapnia) increase neuronal
damage in the Rice–Vannucci rat model compared to mild hypercapnia, corresponding to 6–9% CO2
inhalation [47]. However, in a subsequent study, a detrimental effect of more severe hypercapnia
(12–15% CO2 inhalation) has been demonstrated [48]. In our experiments, the concentration of inhaled
CO2 was 20% to achieve pCO2 values corresponding with those recorded in “natural” birth asphyxia
in piglets and humans [49–51]. This severe hypercapnia likely rather contributes to neuronal damage
during asphyxia in our model at least in part through the severe cerebral acidosis that exceeds the
systemic (blood) acidosis by more than 0.8 pH unit (6.79 vs. 5.94 for blood and brain extracellular
pH), respectively [52]. Hypocapnia has been shown to be detrimental to the brain not only during
hypoxic/ischemic stress but also in the resuscitation/reoxygenation period [20,53]. Hypocapnia may
signal impaired restoration of cellular metabolism, predicting unfavorable outcome of resuscitation
efforts [54]. Furthermore, hypocapnia can be a consequence of relative hyperventilation in response to
metabolic acidosis, and prevention of hypocapnia by inhalation of 5%CO2 may enhance the efficacy of
TH [55]. The question of whether increased CO2 levels (hypercapnia) maintained while establishing
normoxia after asphyxia would convey neuroprotection has been proposed by a set of rat studies
employing asphyxia very similar to the one employed in piglets in the present study [19,20,54]. In these
studies, the graded restoration of normocapnia has been shown to enhance endogenous protecting
mechanisms, preventing rapid restoration and overshoot of cerebral pH and improving oxygenation,
importantly also counteracting seizures, suggesting a profound neuroprotective effect.
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There is no clear explanation for the lack of efficacy of the combined treatment of either H2
or graded restoration of normocapnia with TH, as their precise mechanism of action is unknown.
As neither treatment was tested under normothermic conditions in this study, it is possible that they
could have exerted neutral or even detrimental effects in this experimental paradigm. Alternatively,
hypothermia, H2 or graded restoration of normocapnia may target the activation of similar or even the
same pro-survival mechanisms, and either one may activate these alone as efficiently as combined
with each other. For instance, TH, CO2, and even H2 are known to reduce neuronal excitability and
metabolism, providing means for the occlusion of protective effects [55–58].
Asphyxia-induced changes in gene expression are well-known to affect neuronal viability.
However, data from large animal models are quite limited, and the results from these studies do not
necessarily confirm findings established in rodents. For example, phosphorylation of extracellular
signal-regulated kinases (ERK) and protein kinase B (Akt) were shown to be protective in the brains of
neonatal rodents, suggesting the activation of anti-apoptotic signaling pathways [26,59,60]. In contrast,
in our previous piglet study, we clearly demonstrated that baseline activation levels of ERK and Akt
are very high even under normoxic conditions in the perinatal period in newborn pigs, and these
phosphorylation levels—although they can be modified by selective inhibitors of ERK and Akt
kinases—remain unaffected after asphyxia [61]. Therefore, it is of great importance to re-study these
molecular pathways in large animal models, as these differences can explain the translation block that
often appears with neuroprotective mechanisms operating in small but not large animal brains.
BDNF, AIF, and caspase-3 mRNA levels were assessed in this study as these genes have been
previously shown to be involved in neuronal injury/survival associated with HIE and TH in piglet
models [25,27,62,63]. Postnatal stimulation of BDNF and its downstream elements with dietary
supplements has been shown to promote cognitive development in piglets [62]. Furthermore,
BDNF expression was upregulated by nicotine in the early phase (4 h) of HIE development triggered
with hypoxia in piglets, suggesting therapeutic potential for nicotine [25]. Olson et al. found that BDNF
mRNA was upregulated by the applied hypoxic/ischemic insult itself, and the response was unaltered
by the cooling temperatures (35, 33.5, or 30 ◦C) employed in the study [27]. However, we observed that,
compared to control-normothermic animals, BDNF mRNA levels were essentially the same as in the
asphyxia-normothermia group. However, we did observe a significant increase in BDNF mRNA levels
in the asphyxia-hypothermia group in three regions: the occipital cortex, the hippocampus, and the
caudate nucleus. These findings suggest that hypoxia/ischemia and asphyxia may have different effects
on BDNF expression in the piglet brain, and BDNF overexpression may have a role in the mechanism
of hypothermia-induced neuroprotection. AIF and caspase-3 activation were involved in neuronal
apoptosis in the frontal cortex following global cerebral ischemia, and expression of these factors
was reduced by TH in minipigs [63]. Wang et al. reported that rewarming from hypothermia after
HI was associated with apoptosis in the motor and piriform cortex in a piglet model [64]. Rapidly
rewarmed piglets (4 ◦C/h) had more caspase-3 cleavage in cerebral cortex than did piglets that remained
hypothermic or piglets that were rewarmed slowly (0.5 ◦C/h). Using a caspase-3 inhibitor, apoptosis
was suppressed with rewarming. These results suggest that rewarming from hypothermia after HI
may promote apoptosis through pathways involving caspases [64]. However, rapid or slow rewarming
may have an indirect effect on the brain; a recent elegant study of prenatal lambs demonstrated that
slow or rapid rewarming has no effect on neuronal survival if the hypothermia treatment is restricted
to the brain, and there is no systemic hypothermia [65]. We found that TH after asphyxia upregulated
both AIF and caspase-3 mRNA levels in the hippocampus, but only AIF and not caspase-3 in the
caudate nucleus, coinciding with the selective neuroprotective effect of TH in the caudate nucleus.
Our results are preliminary as they are limited to mRNA levels; therefore, no speculation about protein
levels let alone activity should be assumed based on these findings alone.
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4. Materials and Methods
4.1. Animals
Ethical approval and permission to conduct the animal experiments were obtained in a
three-step process. First, the project (title: Study of neuroprotective strategies in a hypoxic-ischemic
encephalopathy newborn pig model) was first reviewed and approved by the Institutional Animal
Care and Use Committee of the University of Szeged (MÁB, project id nr.: I.74–7/2015, approved on
26 February 2015). Second, the project was forwarded to, reviewed, and approved by the Hungarian
National Scientific Ethical Committee on Animal Experimentation (ÁTET). Third, based on the approval
and recommendation by the ÁTET, the permit to obtain the animals was issued by the government
agency National Food Chain Safety and Animal Health Directorate of Csongrád County, Hungary
(permit nr: XIV./1414/2015, approved on 29 April 2015). The procedures were performed according to
the guidelines of the Scientific Committee of Animal Experimentation of the Hungarian Academy of
Sciences (updated Law and Regulations on Animal Protection: 40/2013. (II. 14.) Gov. of Hungary),
following the EU Directive 2010/63/EU on the protection of animals used for scientific purposes and
reported in compliance with the ARRIVE guidelines.
Newborn (<24 h old) male Landrace piglets (n = 48, weighing between 1.5 and 2.5 kg) were
obtained from a local company (Pigmark Ltd., Co., Szeged, Hungary) and delivered to the laboratory
on the morning of the experiments. The animals were anesthetized with an intraperitoneal injection of
sodium thiopental (45 mg/kg; Sandoz, Kundl, Austria). The animals were placed on a servo-controlled
heating pad (Blanketrol III, Cincinnati SUB-zero, Cincinnati, OH, USA), keeping their core temperature
in the physiological range (38.5 ± 0.5 ◦C). The skin was disinfected, and the animals were intubated
through a tracheotomy and then mechanically ventilated with warmed, humidified medical air (21% O2,
balance N2) at a frequency of 30–35 breaths/min, using a pressure controlled ventilator applying peak
inspiratory pressure = 120–135 mmH2O. Aseptic technique was followed during all aspects of the
animal surgery. With the exception of the untreated naïve animals, the right carotid artery and femoral
vein were cannulated with catheters. To maintain anesthesia/analgesia, the animals were given first a
bolus injection of morphine (100 µg/kg; Teva, Petach Tikva, Israel) and midazolam (250 µg/kg; Torrex
Pharma, Vienna, Austria) and then given a continuous infusion of morphine (10 µg/kg/h), midazolam
(250 µg/kg/h), and fluids (5% glucose, 0.45% NaCl 3–5 mL/kg/h) through the femoral vein catheter.
The right carotid artery catheter was placed for continuous monitoring of MABP and HR throughout
the whole experiment. The wounds were closed and covered with warm compress to minimize heat
and fluid losses. The animals were placed into a neonatal incubator (SPC 78-1; Narco Air-Shields,
Inc., Hatboro, PA, USA). Oxygen saturation, mean arterial blood pressure (MABP), heart rate (HR),
and electrocardiogram (ECG) were continuously monitored using a Hewlett-Packard M1094 monitor
(Palo Alto, CA, USA) and recorded online (MecifView, Arlington, TX, USA). Core temperature was
maintained rigorously at 38.5± 0.5 ◦C with a servo-controlled heating pad. Prophylactic antibiotics were
given intravenously (penicillin: 50 mg/kg/12 h, Teva, Petah Tikva, Israel and gentamicin: 2.5 mg/kg/12 h,
Sanofi, Paris, France) and the urinary bladder was tapped by suprapubic puncture every 12 h. Arterial
blood gases, along with blood sugar and lactate levels, were determined (~300 µL/sample; EPOC Blood
Analysis, Epocal Inc., Ottawa, ON, Canada) at baseline, at the end of asphyxia, and then at selected
intervals up to 47 h to keep blood gas values in the physiological range during the survival period.
4.2. Experimental Protocol
4.2.1. Electroencephalography (EEG)
EEG activity was recorded via subcutaneously inserted silver electroencephalograph (Natus
Neurology, Middleton, WI, USA) electrodes above the fronto-parietal and occipital cortex with 256 Hz
sampling rate (Figure 9). The impedance of all electrodes was checked to be below 5 kΩ. EEG signal
was amplified (Nicolet EEG v32, Natus Medical Inc, San Carlos, CA, USA), recorded, and visualized
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online during the entire experiment with the manufacturer’s software (Nicolet One). Data were stored
on a hard disc and were analyzed offline. Then, 10 min EEG intervals recorded at the beginning of each
hour after asphyxia were scored using an amplitude-based scoring system (Table S1) [15,66]. Briefly,
continuous and high-amplitude background activities (>10 µV) were given lower scores while severely
depressed and isoelectric activities (<10 µV) received higher ones. In addition, if seizures appeared in
the evaluated hour, 2 extra points were added. EEG monitoring was followed by the American Clinical
Neurophysiology Society’s guidelines on continuous EEG monitoring in neonates [67].Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 14 of 22 
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Figure 9. Plan view of the piglet scalp with the modified neonatal EEG montage according to the
international 10–20 system.
Visual evoked potentials (VEP) were evoked with 1 Hz flash using a stroboscope. At least 100 trials
were averaged in each animal for determining the stable average VEP waveform. Grand mean averages
were calculated for the P100 peak’s (O1 and O2 electrodes) amplitude and latency changes. The process
of evoking VEPs followed the American Clinical Neurophysiology Society’s guidelines on visual
evoked potentials [68].
4.2.2. EEG Spectral Analysis
The broad band signals were filtered, applying a bandpass filter (1–30 Hz). After signal
decomposition (delta (1–4 Hz), theta (4–8 Hz), alpha (8–13 Hz), beta (13–30 Hz)), we calculated
the PSDs. We used the fast Fourier transform (FFT) of the signal by applying a 30 s moving window
with 1 s steps, using a Gaussian window. All PSD values were estimated by using the Welch’s method.
The determined PSDs were summed, averaged, and normalized to the baseline level for each frequency
band [32].
InstSpEnt and SpEnt calculations were based on Shannon entropy or information entropy [69].
The calculated Shannon entropy reflects the signal’s normal power distribution in the frequency
domain. It is also commonly used to determine the depth of the anesthesia [70]. The SpEnt values
were thresholded, setting the level to the standard deviation of the SpEnt (threshold = mean − SD).
Thresholding was necessary due to the length of the signal (we did not use segmentation), averaging,
and the quite narrow window sizes for each frequency band. The thresholded values were compared
with the InstSpEnt. The SpEnt were presented as individual values for each group and channel. We also
used Shannon entropy for seizure detection.
All data analysis was performed in the MATLAB (Mathworks Inc., Natick, MA, USA) environment
with appropriate toolboxes [71], built-in functions, and custom written scripts. Plotting the SpEnt,
we used a function written by Rob Campbell (2020), notBoxPlot (https://github.com/raacampbell/
notBoxPlot), GitHub.
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4.2.3. Cortical H2 Concentration Measurements
In additional animals (n = 3), we performed craniotomy while the animal’s head was fixed in
a stereotaxic frame. H2 microsensors (external tip diameter: 50 µm) were obtained from Unisense
(Aarhus, Denmark). We mounted the electrode to a stereotaxic manipulator for the 2-point calibration.
Before the calibration and the measurements, the electrode was polarized at +1000 mV for 1 h. The
zero H2 reading was done in water phase, vigorously bubbled with N2 gas for at least 5 min in the
CAL300 calibration chamber (Unisense, Aarhus, Denmark). Maximal H2 reading was done in water
phase and calibration chamber as well, bubbled vigorously with a gas mixture containing 95% N2 and
5% H2. In this case, the H2 partial pressure was 0.05 ATM and the solubility was 794.64 µmol/L/atm at
22 ◦C. To calculate the maximal concentration, we multiplied the partial pressure with the solubility,
which was 39.732 µM [72]. Data were recorded with 1 Hz sampling rate in SensorTrace Logger software
(Unisense, Aarhus, Denmark). Calibrations were performed at room temperature; thus, during data
analysis, we applied temperature correction.
4.3. Experimental Groups
Experimental protocol is outlined in Figure 1. Animals participating in the experiment were
divided into 6 groups as follows. (1) Untreated animals served as naïve controls for neuropathology and
gene expression studies (naïve, n = 7). After the surgical procedure, one hour of recovery period allowed
stabilization of monitored physiological parameters prior obtaining baseline values. After recording
the baseline physiologic parameters, animals were divided into 5 additional groups: (2) normoxic
time controls (control-normothermia; n = 5) with 48 h of survival; (3) animals undergoing 20 min
asphyxia (asphyxia-normothermia; n = 7); (4) asphyxia combined with mild whole body hypothermia
(asphyxia-hypothermia; n = 7); (5) asphyxia combined with 4 h of hydrogen ventilation combined with
mild whole body hypothermia (asphyxia-hypothermia+H2; n = 8); (6) asphyxia combined with 4 h of
CO2 ventilation combined with mild whole body hypothermia (asphyxia-hypothermia+CO2; n = 7).
The piglets among the four asphyxia-exposed groups were randomized with two consecutive coin
flips. Asphyxia in groups asphyxia-normothermia, asphyxia-hypothermia, asphyxia-hypothermia+H2,
and asphyxia-hypothermia+CO2 was induced by ventilation with a hypoxic/hypercapnic gas mixture
containing 4% O2 and 20% CO2 for 20 min while respiratory rate was reduced from 30 to 15 breaths/min,
and intravenous glucose administration was suspended. Arterial blood gas was determined to check
the severity of perinatal asphyxia at the 19th min of asphyxia. Piglets were reventilated (respiration rate;
RR: 30 1/min) in asphyxia-normothermia and asphyxia-hypothermia groups with room air, whereas in
the asphyxia-hypothermia+H2 group, this was achieved with a gas mixture containing hydrogen gas
(2.1% H2, 21% O2, balance N2). After 4 h, hydrogen treatment was stopped and ventilation with room
air was restored. In the asphyxia-hypothermia+CO2 group, piglets were reventilated with a normoxic
hypercapnic gas mixture containing 10% CO2 for 2 h and thereafter 5% CO2 also for 2 h. Ventilation
was continued with room air throughout the survival period.
In groups designated to receive hypothermia, we delayed the induction of hypothermia by 2 h
to mimic clinical delays in inducing hypothermia. At 2 h after asphyxia, we induced whole-body
hypothermia to a goal rectal temperature of 33.5 ◦C by using servo-controlled heating pad. Rectal
temperature decreased to 33.5 ◦C in ~40 min, and rectal temperature has been found to track brain
temperature within 0.2 ◦C in this model [66]. Piglets remained hypothermic for 34 h. At 36 h after
asphyxia, we initiated whole-body rewarming at 0.5 ◦C/h by increasing the water temperature
circulating through the warming blanket until normothermia (38.5 ◦C) was reached. All piglets were
euthanized at 48 h after asphyxia. Both carotid arteries were catheterized in the distal direction
and the brains were perfused through them with cold (4 ◦C) physiological saline. The brains were
gently removed from the skull, and tissue samples (~100 mg) taken from the left hemisphere (frontal-,
parietal-, temporal-, occipital cortex; hippocampus, caudate nucleus, putamen, thalamus) were snap
frozen in liquid N2 and stored at −80 ◦C before total ribonucleic acid (RNA) isolation. The intact right
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hemispheres were immersion-fixed in 4 ◦C, 4% paraformaldehyde solution and further processed for
histology after two weeks.
4.4. Histology
Paraffin-embedded, 4-µm sections were produced from the frontal, temporal, parietal, occipital
lobes as well as the hippocampus CA1/CA3, thalamus, putamen, and nucleus caudatus areas
using a microtome (Leica Microsystems, Wetzlar, Germany) and mounted on sylanized slides.
Hematoxylin-eosin staining was performed to evaluate the extent of neuronal damage in the thalamus,
putamen, nucleus caudatus, and the hippocampal CA1 and CA3 regions, which was assessed with
manual cell counting by two independent observers in non-overlapping areas using ImageJ software
(Wayne Rasband, NIH, Bethesda, MD, USA) (Figure 7B–F). Damaged neurons were identified using the
major hallmarks of dark eosinophilic cytosol, as well as pyknotic or disrupted nuclei, by a researcher
blinded to the experimental groups. The impact of asphyxia on subcortical brain regions was expressed
as the percentage of damaged neurons.
In the cerebral cortex, however, neuropathology scores were determined (0–9) as described
previously [15,16]. (Table 1). Briefly, the pattern of neuronal injury (none < scattered < grouped/laminar
< panlaminar) was assessed in 40 non-overlapping fields of vision under 20×magnification with light
microscopy (Leica Microsystems, Wetzlar, Germany) in each cortical region. Then, neuropathology
scores (0–9) were given to each region based on the occurrence of the most severe pattern of injury
observed. Thus, higher scores represented increasingly severe neuronal damage (Figure 7A).
Table 1. Cortical neuronal injury was determined using a neuropathology scoring system based on the
occurrence of the most severe pattern observed in 40 visual fields. Higher scores represent more severe
neuronal damage. Representative photomicrographs are shown in Supplementary Figure S6.
Score Morphology of Cortical Damage Ratio of the Most Severe Pattern per Area
0 No damage
1
Scattered
<20%
2 21–50%
3 >50%
4
Grouped
<20%
5 21–50%
6 >50%
7
Panlaminar
<20%
8 21–50%
9 >50%
4.5. Total RNA Extraction and cDNA Synthesis
Total RNA was extracted from homogenized brain tissues of the frontal and the occipital cortex,
the hippocampus, and the caudate nucleus with Tri Reagent (Sigma, St. Louis, MA, USA) according
to the manufacturer’s protocol. Briefly, 1 mL Tri Reagent was added to the homogenized samples.
After 5 min incubation at room temperature to allow dissociation of nucleoprotein complexes, 0.2 mL
of chloroform was added. The samples were mixed vigorously and then centrifuged at 12,000× g
for 15 min at 4 ◦C. After centrifugation, the RNA was precipitated from the upper, colorless aqueous
phase with 0.5 mL of isopropanol. The samples were then incubated at room temperature for 10 min
and centrifuged at 12,000× g for 10 min at 4 ◦C. The supernatant was removed and the RNA pellet
was washed once with 75% ethanol. The pellet was air dried and dissolved in diethyl pyrocarbonate
(DEPC)-treated water. Total RNA quantity (OD260) and purity (OD260/280) were measured by a
NanoDrop spectrophotometer (Thermo Scientific, Waltham, MA, USA)
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4.6. Quantitative PCR Analyses
For quantitative PCR (qPCR), 1 µg of total RNA was reverse transcribed using the Maxima Reverse
Transcriptase according to the manufacturer’s protocol with random hexamer priming (Thermo Fisher
Scientific Inc. Waltham, MA, USA). qPCR was performed in a Bio-Rad CFX96 real-time system with
the MaximaTM SYBR Green qPCR Master Mix (2X) (Thermo Fisher Scientific Inc. Waltham, MA, USA)
and primers were designed specifically using the Sus scrofa domestica (white pig) Ensembl database
as follows: BDNF: F: AGCGTGTGCGACAGCATTAG, R: GTCCACTGCCGTCTTTTTATCC; AIF: F:
AGGACTCCTTCCATCACAATGTG, R: TTGGCAAACCCCCTTTCC; Caspase-3: F: AGCGCTGAAAC
AGTATGTTCACA, R: TTCTACTGCTACCTTTCGGTTAACC.
The reference genes (peptidylprolyl isomerase A; (PPIA) and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH)) were chosen to standardize all quantitative experiments: PPIA2: F:
ATA CGG GTC CTGGCA TCT TG, R: AAC TGG GAA CCG TTT GTG TTG; GAPDH: F: GGAAGC
TTGTCATCAATGGAAAGG, R: ACCAGCATCACCCCATTTGA.
To check the amplification specificity, the qPCR was followed by a melting curve analysis.
For each duplicate sample, threshold cycles (Ct) were calculated for BDNF, AIF, caspase-3, PPIA2,
and GAPDH genes, and the normalized gene expressions were calculated by the ∆∆Ct method.
Statistical comparison of qPCR data was performed by comparing the ∆∆Ct values of untreated and
treated brain samples.
4.7. Statistical Analysis
Statistics were calculated using the software package SigmaPlot (v12.0, Systat Software, Chicago,
IL, USA) or MATLAB (Mathworks Inc., Natick, MA, USA).
Differences in core temperature, MABP, and HR at each time point were analyzed with two-way
ANOVA with repeated measures. Differences in arterial pH, arterial pCO2, arterial pO2, blood glucose,
blood lactate, and delta base excess were compared between the groups at the different time points by
two-way ANOVA with repeated measures as well. Comparisons were conducted in each case using
Student–Newman–Keuls post hoc test. Data are presented as standard error of the mean (SEM).
All electrophysiological data were analyzed in IBM SPSS 22. For the SpEnt, we used one-way
ANOVA with repeated measures; for the PSD and the VEP, we performed two-way ANOVA with
repeated measures. Pairwise comparisons were conducted in each case using Tukey’s post hoc test.
Data are presented as mean ± SD.
Histological data were analyzed using one-way ANOVA or Kruskal–Wallis analysis of ranks.
Pairwise comparisons were conducted in each case using Student–Newman–Keuls post hoc test when
appropriate. Data are presented as standard error of the mean (SEM). The observed power of the
pairwise comparisons in the different regions was the following: cortex: 0.63, hippocampal CA1: 0.11,
CA3: 0.11, caudate nucleus: 0.84, putamen: 0.28, thalamus: 0.12.
Expression of BDNF, AIF, and caspase-3 genes normalized to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) and peptidylprolyl Isomerase A2 (PPIA2) was compared by one-way
ANOVA or Kruskal–Wallis analysis of ranks. Pairwise comparisons were conducted in each case using
Dunn’s post hoc test.
Statistical significance was defined as p < 0.05.
5. Conclusions
In newborn pigs, we elicited HIE with experimental asphyxia, leading to neuronal injury that
could not be prevented by TH alone. Combination of TH with putative neuroprotective gas therapies
such as inhaled molecular H2 or CO2 to achieve graded restoration of normocapnia did not enhance
or complement hypothermia-induced neuroprotection. Based on the findings of the present study,
using these gas therapies with these treatment parameters is not recommendable in neuroprotective
HIE management.
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Abbreviations
AIF apoptosis induction factor
Akt protein kinase B or PKB
A-HT asphyxia-hypothermia
A-NT asphyxia-normothermia
BDNF brain-derived neurotrophic factor
C-NT control-normothermia
COX-2 cyclooxygenase-2
CREB cAMP response element binding protein
Ct threshold cycles
DEPC diethyl pyrocarbonate
DNA deoxyribonucleic acid
ECG electrocardiogram
EEG electroencephalogram
ERK extracellular signal-regulated kinase
FFT fast Fourier transform
GAPDH glyceraldehyde 3-phosphate dehydrogenase
HI hypoxia/ischemia
HIE hypoxic-ischemic encephalopathy
HR heart rate
InstSpEnt instantaneous spectral entropy
MABP mean arterial blood pressure
MAPK mitogen-activated protein kinase
mRNA messenger ribonucleic acid
PI-3-K phosphatidylinositol-3-kinase
PPIA peptidylprolyl isomerase A or cyclophilin A
PSD power spectral density
qPCR quantitative polymerase chain reaction
RNA ribonucleic acid
RR respiration rate
SpEnt spectral entropy
TH therapeutic hypothermia
TrkB tyrosine kinase B
VEP visual evoked potential
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neuroprotection in a translational piglet model of hypoxic-ischemic encephalopathy. J. Physiol. Pharmacol.
2016, 67, 677–689.
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